Dr. Gust Bardy, president of the Seattle Institute for Cardiac Research and lead investigator of the Home Automated External Defibrillator Trial (HAT), published in the New England Journal of Medicine, will discuss the use of automated external defibrillators, both at home and in public locations, as a strategy to reduce mortality rates among patients who are at higher risk for sudden cardiac death.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
AEDs: Limiting Rates of Sudden Cardiac Death
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Recommended
Details
Presenters
Comments
Recommended
Overview
Dr. Gust Bardy, president of the Seattle Institute for Cardiac Research and lead investigator of the Home Automated External Defibrillator Trial (HAT), published in the New England Journal of Medicine, will discuss the use of automated external defibrillators, both at home and in public locations, as a strategy to reduce mortality rates among patients who are at higher risk for sudden cardiac death.
Facebook Comments